SCHEMBL4064862

SCHEMBL4064862

CCCOc1ccc(C#Cc2ccc(OC(=O)OC(C)(C)C)cc2)cc1

nearest known ligand 0.60

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ACACB O00763 17/20 0.60
ELANE P08246 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4065254 0.88 ELANE (0.55) ACACBELANEL3MBTL1
SCHEMBL4065386 0.84 ELANE (0.51) ACACBELANE
SCHEMBL13845217 0.84 ELANE (0.51) ACACBELANEL3MBTL1
SCHEMBL4061895 0.84 ELANE (0.59) ACACBELANEL3MBTL1
SCHEMBL4058555 0.84 ELANE (0.59) ACACBELANEL3MBTL1
SCHEMBL13845193 0.83 ELANE (0.50) ACACBELANEL3MBTL1
SCHEMBL4059293 0.83 ACACB (0.56) ACACBL3MBTL1
SCHEMBL4061308 0.82 ELANE (0.49) ACACBELANEL3MBTL1
SCHEMBL4064336 0.82 ELANE (0.58) ACACBELANEL3MBTL1
SCHEMBL11969670 0.81 ACACB (0.65) ACACBL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7534547-B2 Optically active compound and photosensitive resin composition OSAKA GAS COMPANY LIMITED (JP) 2009-05-19 US disclosed
US-7534547-B2 Optically active compound and photosensitive resin composition OSAKA GAS COMPANY LIMITED (JP) 2009-05-19 US disclosed
EP-1375463-A1 OPTICALLY ACTIVE COMPOUND AND PHOTOSENSITIVE RESIN COMPOSITION Kansai Research Institute, Inc. (JP) 2004-01-02 EP disclosed
US-20030211421-A1 Optically active compound and photosensitive resin composition KRI, INC. (JP) 2003-11-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030211421-A1 Optically active compound and photosensitive resin composition ARCN1, RAD51, PAM ACACB 4685/4885ELANE 422/4885L3MBTL1 2831/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.